Future of AZ-BMS diabetes drug in doubt
July 20, 2011Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news
A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
Hep C drug Victrelis gains EU approval
July 20, 2011Sales and Marketing Incivek, Victrelis, hepatitis C
Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …
Contract research news in brief
July 20, 2011Research and Development research and development news
M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
Government seeks to salvage pharma pricing reforms
July 19, 2011Sales and Marketing NICE, value-based pricing
The government is pushing ahead with plans to introduce value-based pricing in 2014, despite acknowledging the new system still requires …
Hepatitis C rivals go head to head
July 19, 2011Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …
Novartis posts double-digit sales and profit growth
July 19, 2011Sales and Marketing Novartis
Novartis had a strong second quarter of the year, with both sales and profit up on the same period in …
In search of authenticity
July 19, 2011Sales and Marketing
We don’t have a sales consultant in front of us in that situation. There is nobody to demonstrate and reassure …
Sweden seeks GMP revisions to tackle environmental pollution
July 19, 2011Manufacturing and Production pharma manufacturing news
Wholesale shifting of pharmaceutical production to low-cost countries such as India and China is creating environmental impacts “on a scale …
Lonza wins another antibody contract
July 19, 2011Manufacturing and Production Immune Pharmaceuticals, Lonza, pharma manufacturing news
Lonza has won a contract to manufacture Immune Pharmaceuticals’ antibody-based drug for inflammatory disorders, bertilimumab, at its mammalian development and …
New joint venture plans to tap into global generics market
July 19, 2011Ajinomoto OmniChem, Granules India, pharma manufacturing news
Belgian fine chemicals company Ajinomoto OmniChem has forged a joint venture with Granules India to produce active pharmaceutical ingredients and …
ASCO 2011: news from the front line against cancer
July 18, 2011Research and Development ASCO, Cancer, oncology
Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
NICE decides laser treatment better than Lucentis
July 18, 2011Sales and Marketing Lucentis, NICE, Novartis
Novartis says it is “disappointed” with health watchdog NICE’s decision not to recommend Lucentis for the treatment of eye problems …
Amgen bone cancer drug Xgeva approved in Europe
July 18, 2011Sales and Marketing Amgen, Prolia, Xgeva, denosumab
Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Already …
GSK downsizes Irish OTC plant
July 18, 2011Manufacturing and Production GSK, Ireland, pharma manufacturing news
GlaxoSmithKline is cutting around 130 jobs at a facility in Waterford, Ireland, over the next three years as part of …
Pharma manufacturing news in brief
July 18, 2011Manufacturing and Production pharma manufacturing news
Our round-up of news in the pharmaceutical manufacturing sector includes facility updates from NanoSonic, Tianyin Pharma, Orchid and Boehringer Ingelheim, …
Digital Pharma: iPhone and iPad app update
July 15, 2011Medical Communications, Sales and Marketing Blackberry, Digital Pharma blog, ipad, iphone, mobile
How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey? Do Novartis’ investors really want their annual …
Lophius Biosciences expands management team
July 15, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …
Reynolds-MacKenzie joins Open Health
July 15, 2011Medical Communications medical communications agency, medical communications news
Specialist health agency Reynolds-MacKenzie has become the latest recruit to the Open Health stable, bolstering the new communications group’s PR …
The changing fortunes of NICE and health secretaries
July 15, 2011Sales and Marketing NICE
You might not have noticed, but the government has performed a major U-turn. No, I don’t mean the NHS reform …
UK pricing reform derailed
July 15, 2011Sales and Marketing NICE, PPRS, value-based pricing
Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
